openPR Logo
Press release

Organ Transplant Rejection Medication Market Revenue to Cross $7.0 billion by 2031 to Rise at a Stellar CAGR of 3.9% | Transparency Market Research

02-27-2024 11:30 AM CET | Health & Medicine

Press release from: Transparency Market Research

Organ Transplant Rejection Medication Market Revenue to Cross

Organ transplantation stands as a beacon of hope for patients suffering from end-stage organ failure, offering a chance at extended life and improved quality of life. However, the success of organ transplantation hinges on effective immunosuppressive therapy to prevent rejection, a significant challenge faced by transplant recipients. The organ transplant rejection medication market plays a pivotal role in providing the pharmaceuticals necessary to mitigate rejection risk and ensure graft survival. This article delves into the intricate landscape of the organ transplant rejection medication market, exploring its dynamics, key players, recent developments, and future prospects.

The organ transplant rejection medication market encompasses a diverse array of immunosuppressive agents used to prevent and treat rejection reactions following solid organ transplantation. These medications target the recipient's immune system to suppress immune responses against the transplanted organ, thereby preserving graft function and ensuring long-term transplant success.

Organ Transplant Rejection Medication market is estimated to attain a valuation of US$ 7.0 Bn by the end of 2031, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 3.9% during the forecast period, 2022-2031

Get a Sample Copy of the Organ Transplant Rejection Medication Market Research Report -

The significant players operating in the global Organ Transplant Rejection Medication market are

Pfizer, Inc., Astellas Pharma, Inc., Novartis AG, F. Hoffmann-La Roche Ltd., Sanofi, Bristol-Myers Squibb Company, GlaxoSmithKline plc, AbbVie, Inc., Hansa Biopharma, WOCKHARDT, Viatris, Inc., Glenmark, Biocon, Hikma Pharmaceuticals plc, Teva Pharmaceutical U.S.A Inc., and Zydus Pharmaceuticals

Drivers of Market Growth:

Rising Organ Transplantation Rates: The increasing prevalence of end-stage organ failure, coupled with advancements in surgical techniques and organ procurement processes, has led to a steady rise in organ transplantation rates worldwide. The growing demand for transplantable organs drives the need for effective immunosuppressive therapies, fueling market growth.

Expanding Indications for Transplantation: Organ transplantation is no longer limited to life-saving procedures but also extends to improve patients' quality of life. Expanding indications for transplantation, such as kidney, liver, heart, lung, pancreas, and combined organ transplants, broaden the market scope for organ transplant rejection medications.

Advancements in Drug Development: Pharmaceutical companies continue to invest in research and development efforts to enhance the efficacy, safety, and tolerability of immunosuppressive agents. Novel drug formulations, targeted therapies, and combination regimens offer opportunities for improved transplant outcomes and reduced adverse effects.

Increasing Access to Transplantation Services: Efforts to improve access to transplantation services, including transplant centers, organ procurement organizations, and transplant networks, facilitate timely organ allocation and transplantation. Expanded access to transplantation drives demand for immunosuppressive medications, contributing to market growth.

Buy this Premium Research Report: -<ype=S

Future Opportunities in the Organ Transplant Rejection Medication Market:

Next-Generation Immunosuppressants: Continued research into novel immunosuppressive agents, including small molecule inhibitors, biologics, and gene therapies, presents opportunities for next-generation transplant rejection medications with improved efficacy, safety, and tolerability profiles.

Precision Medicine Approaches: Advances in precision medicine, including genomics, proteomics, and metabolomics, enable personalized immunosuppression strategies tailored to individual patient characteristics, transplant type, and immune response profiles. Precision medicine approaches optimize transplant outcomes and minimize the risk of rejection and drug toxicity.

Biosimilar Development: The development of biosimilar versions of established immunosuppressive agents offers cost-effective alternatives to branded medications, enhancing accessibility and affordability of transplant rejection therapies. Biosimilars promote market competition, drive down drug prices, and expand treatment options for transplant recipients.

Regenerative Medicine Therapies: Regenerative medicine approaches, such as cell-based therapies, tissue engineering, and organ biofabrication, hold potential for inducing immune tolerance and promoting graft acceptance in organ transplantation. Regenerative medicine therapies offer alternative strategies for transplant tolerance induction and long-term graft survival.

Market Segmentation -

Drug Class
Calcineurin Inhibitors
mTOR Inhibitors

Transplant Type

Distribution Channel
Hospitals Pharmacies
Retail Pharmacies
Online Pharmacies

This Report lets you identify the opportunities in Organ Transplant Rejection Medication Market by means of a region:

North America (the United States, Canada, and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, and Southeast Asia (Indonesia, Thailand, Philippines, Malaysia, and Vietnam))
South America (Brazil etc.) The Middle East and Africa (North Africa and GCC Countries)

Reasons to Buy The Organ Transplant Rejection Medication Market Report: -

1.Regional report analysis highlighting the consumption of products/services in a region also shows the factors that influence the market in each region.

2.Reports provide opportunities and threats faced by suppliers in the Organ Transplant Rejection Medication industry around the world.

The report shows regions and sectors with the fastest growth potential.

3.A competitive environment that includes market rankings of major companies, along with new product launches, partnerships, business expansions, and acquisitions.

4.The report provides an extensive corporate profile consisting of company overviews, company insights, product benchmarks, and SWOT analysis for key market participants.

5.This report provides the industry's current and future market outlook on the recent development, growth opportunities, drivers, challenges, and two regional constraints emerging in advanced regions.

More Trending Reports by Transparency Market Research -

Atopic Dermatitis Drugs Market-

CINV Existing and Pipeline Drugs Market-

About Us Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.

Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.

๐‚๐จ๐ง๐ญ๐š๐œ๐ญ ๐”๐ฌ
Nikhil Sawlani
Transparency Market Research Inc.
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Organ Transplant Rejection Medication Market Revenue to Cross $7.0 billion by 2031 to Rise at a Stellar CAGR of 3.9% | Transparency Market Research here

News-ID: 3401384 • Views: โ€ฆ

More Releases from Transparency Market Research

Handheld Marijuana Vaporizer Market Key Drivers, Market Research, and Insights for the USD 15.9 Bn Market 2022-2031
Handheld Marijuana Vaporizer Market Key Drivers, Market Research, and Insights f โ€ฆ
The global handheld marijuana vaporizer market has witnessed remarkable growth in recent years, attributed to the increasing acceptance of medicinal marijuana and the demand for convenient and discreet consumption methods. Valued at US$ 5 billion in 2021, the market is projected to surge at a CAGR of 13.4% to reach US$ 15.9 billion by 2031. This article delves into the factors driving this growth, the evolving market landscape, and theโ€ฆ
Disinfectant Wipes Market Forecast 2020-2030 - Market Size, Drivers, Trends, And Competitors
Disinfectant Wipes Market Forecast 2020-2030 - Market Size, Drivers, Trends, And โ€ฆ
The COVID-19 pandemic has precipitated a remarkable surge in the demand for disinfectant products, with a notable emphasis on disinfectant wipes as an essential tool in maintaining hygiene and preventing the spread of pathogens. This research report delves into the multifaceted landscape of the disinfectant wipes market, elucidating key trends, drivers, and innovations shaping the industry. ๐†๐ž๐ญ ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐๐ƒ๐… ๐‚๐จ๐ฉ๐ฒ ๐จ๐Ÿ ๐ญ๐ก๐ข๐ฌ ๐ซ๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ @ Key Players and Market Developments Key playersโ€ฆ
Tissue Banking Market is Expected to Reach US$ 2,903.3 Million to 2026| TMR Study
Tissue Banking Market is Expected to Reach US$ 2,903.3 Million to 2026| TMR Stud โ€ฆ
The global ๐ญ๐ข๐ฌ๐ฌ๐ฎ๐ž ๐›๐š๐ง๐ค๐ข๐ง๐  ๐ฆ๐š๐ซ๐ค๐ž๐ญ reached a value of US$ 1,056.4 million in 2017 and is projected to nearly triple to US$ 2,903.3 million by 2026, with a robust Compound Annual Growth Rate (CAGR) of approximately 12.0% from 2018 to 2026. Factors such as increasing awareness about tissue donation, technological advancements, and a growing target patient population are anticipated to propel market growth during this period. Moreover, the market is expectedโ€ฆ
Vascular Closure Devices Market to reach US$ 1 Billion by 2027: TMR Study
Vascular Closure Devices Market to reach US$ 1 Billion by 2027: TMR Study
This report by Transparency Market Research, Inc. assesses the present state and future growth potential of the global ๐ฏ๐š๐ฌ๐œ๐ฎ๐ฅ๐š๐ซ ๐œ๐ฅ๐จ๐ฌ๐ฎ๐ซ๐ž ๐๐ž๐ฏ๐ข๐œ๐ž๐ฌ ๐ฆ๐š๐ซ๐ค๐ž๐ญ. It features a comprehensive executive summary, offering insights into various segments of the market. Additionally, the report provides detailed analysis and data on product, access type, application, end user, and regional segments within the global market. Vascular closure devices is estimated to reach a value of ~US$ 1 Bnโ€ฆ

All 5 Releases

More Releases for Transplant

Global Tacrolimus Injection Market Size, Share & Trends Analysis Report, By Appl โ€ฆ
The global tacrolimus injection market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Tacrolimus, also known as Prograf, is an immunosuppressive drug primarily used with other medications to prevent rejection of a heart, kidney, or liver transplant in adult and pediatric patients. This medication works by supporting the body to accept the new organ and lower the risk of organ rejection so as to preventโ€ฆ
Organ Transplant Market | Organogenesis Incorporated, Terumo Co., OrganOX, Trans โ€ฆ
Organ Transplant Market report is an in-depth analysis study offered which explains necessary aspects like competition, segmentation, and regional growth in excessive detail. As a part of competitive analysis, the analysis study includes thorough company identification of leading players of the world Organ Transplant Market. Organ Transplant Market report provides emerging opportunities in the market and the future impact of major drivers and challenges and, support decision makers in making cost-effectiveโ€ฆ
Transplant Diagnostics Market
Transplant diagnostics is the examination of factors associated with recently performed transplant. This can be elaborated as safety testing, compatibility, testing, transplant feasibility testing, pre, peri, and post transplantation. This is done to check the tissue compatibility between the donor and patient in organ transplant. Major Players: The prominent players in the transplant diagnostics market are Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., QIAGEN, F. Hoffmann-La Roche Ltd., Illumina, Inc., Merck KGaA,โ€ฆ
Kidney Transplant Market
Kidney Transplant Market describes its growth, size, share, Forecast and trends to 2025 Kidney transplant is the most commonly conducted transplant surgery worldwide. It has gained widespread popularity by improving the outcome of end-stage renal disease ESRD patients. With advances in kidney transplant methods and improvement in transplant success, a kidney transplant is now widely considered to be the best way of treating chronic kidney disease for many people. As theโ€ฆ
hair transplant services
Hair transplant is a surgical procedures that moves hair follicles from one part of the body to another part of the body. Hair transplantation is chiefly used to treat the baldness in male and female. The global hair transplant services market is witnessing a rise in its demand. The market is segmented into three major transplant procedures like scalp reduction, follicular unit strip surgery and follicular unit extraction. Increasing importance regardingโ€ฆ
Organ Transplant Immunosuppressant Drugs Market By Drug Class, By Transplant, By โ€ฆ
This report on the organ transplant immunosuppressant drugs market studies the current and future prospects of the global market. Organ transplant immunosuppressant drugs market are prescribed to patients during or after transplant of organs such as kidney, liver, heart, lung and bone marrow. Organ dysfunction caused due to severe injuries, cancer, organ failure and/or genetic disorders necessitate the requirement for organ transplant procedures. Thus, rise in the number ofโ€ฆ